Skip to main content

Table 3 Summary of associations between patient characteristics and ductal lavage cellularity

From: Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation

 

ICMD ducts

Cell count/ml

Total cell count/specimen

 

%

P 1

Median

Range

P 2

Median

Range

P 2

Overall

39

 

600

0 to 909,090

 

9481

0 to 21,818,160

 

FY Status

        

   FY duct

32

 

1625

0 to 909,090

 

30,996

0 to 21,818,160

 

   Non-FY duct

57

0.037

0

0 to 4959

<0.001

0

0 to 173,577

0.002

Menopausal status

        

   Premenopausal

28

 

1000

0 to 50,000

 

22,000

0 to 600,000

 

   Postmenopausal

51

0.034

0

0 to 909,090

0.044

0

0 to 21,818,160

0.055

Previous diagnosis of BC

        

   Previous BC

31

 

1000

0 to 909,090

 

22,000

0 to 21,818,160

 

   No BC

43

0.361

390

0 to 50,000

0.191

6000

0 to 1,229,667

0.189

Parity

        

   Parous

35

 

750

0 to 909,090

 

12,000

0 to 21,818,160

 

   Non-parous

58

0.073

0

0 – 50,000

0.395

0

0 to 600,000

0.261

Breast feeding

        

   Breast fed

31

 

1000

0 to 909,090

 

15,426

0 to 21,818,160

 

   No breast feeding

57

0.024

0

0 to 50,000

0.091

0

0 to 600,000

0.057

BC during study

        

   BC

20

 

6666

0 to 25,850

 

79,992

0 to 542,850

 

   No BC

40

0.645

500

0 to 909,090

0.133

7688

0 to 21,818,160

0.261

Cytologic atypia

        

   Mild atypia

  

5355

84 to 50,000

 

105,870

1920 to 1,229,667

 

   Severe atypia

  

3591

1917 to 18,666

0.75

113,752

48,000 to 447,996

0.892

   Atypia (mild + severe)

0

 

4875

84 to 50,000

 

105,870

1920 to 1,229,667

 

   No atypia

50

<0.001

14

0 to 909,090

<0.001

174

0 to 21,818,160

<0.001

  1. Cellularity is expressed both as cells/ml, to account for variations in the volume of DL collected, as well as total number of cells/specimen in order to permit comparisons between our results and other published studies. P1= Fisher's exact test; P2= Mann-Whitney test. BC, breast cancer; ICMD, inadequate cellular material for diagnosis; FY, ducts producing nipple aspirate fluid.